Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

Overview of attention for article published in BMC Pulmonary Medicine, February 2011

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)

Mentioned by

patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 121 Dimensions

Readers on

mendeley: 109 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ANTI-IL-9 ANTIBODIES AND METHODS OF USE THEREOF

Application WO-2022263357-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.